Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
PHARMA . MANAGEMENT from Liège, company number BE0439966462, closed financial year 2025 with a result of € -1,362 after tax. For that financial year PHARMA . MANAGEMENT recorded a gross margin of € -1,362 and equity of € 190,957. Compared with financial year 2024, the result moved from € 0 to € -1,362. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 190,957
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,362
▼ still € 0 profit in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € 172,357.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -76 | € -462 | - | € -1,362 | |
| Profit after taxes | € -76 | € -642 | € 0 | € -1,362 | |
| Equity | € 192,960 | € 192,319 | € 192,319 | € 190,957 | ▼ 1% |
| Total debts | € 59,383 | € 60,024 | € 57,024 | € 58,386 | ▲ 2% |
| Retained profit | € 174,360 | € 173,719 | € 173,719 | € 172,357 | ▼ 1% |
| Balance sheet total | € 252,343 | € 252,343 | € 249,343 | € 249,343 |
Key figures of PHARMA . MANAGEMENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMA . MANAGEMENT the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMA . MANAGEMENT?
What happened at PHARMA . MANAGEMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1,362. Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 76 loss in 2022 to € 1,362 loss in 2025.
Management
The stake of AF. EVRARD comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMA . MANAGEMENTBehind PHARMA . MANAGEMENT is A.F.EVRARD SRL. The shares are held by AF. EVRARD (99.5%). It owns 99.7% of Pharmacies LONAY-MULKERS itself.
Directors
According to the 2025 annual accounts
Manager · represented by Anne-Françoise EVRARD
Also active at: Pharmacie TROISFONTAINES
Shareholders
99.5%
Participations
99.7%
Establishments
Establishment units
Physical locations of this company
Féronstrée 14
4000 Liège
Rue Agimont 22
4000 Liège
Active since 21 May 1990
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0439.966.462
- VAT number
- BE 0439.966.462
- Registered office
- Féronstrée 14, 4000 Liège
- Names & denominations
- PHARMA . MANAGEMENT
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 8 January 1990
- Peppol
- Not registered